Dr Teri Nelson Moak, MD | |
6045 Barfield Rd Ste 100, Sandy Springs, GA 30328-4402 | |
(404) 250-3333 | |
Not Available |
Full Name | Dr Teri Nelson Moak |
---|---|
Gender | Female |
Speciality | Plastic Surgery |
Location | 6045 Barfield Rd Ste 100, Sandy Springs, Georgia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821479734 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | 2015017254 (Missouri) | Secondary |
208200000X | Plastic Surgery | 97664 (Georgia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Teri Nelson Moak, MD 6045 Barfield Rd Ste 100, Sandy Springs, GA 30328-4402 Ph: () - | Dr Teri Nelson Moak, MD 6045 Barfield Rd Ste 100, Sandy Springs, GA 30328-4402 Ph: (404) 250-3333 |
News Archive
Cellzome today announced that it has formed a second strategic alliance with GlaxoSmithKline (GSK). This new collaboration gives GSK exclusive access to Cellzome's proprietary Episphere(TM) technology in the emerging field of epigenetics as applied to immunoinflammatory disease. Epigenetic mechanisms play a key role in controlling immune cell differentiation and inflammatory gene expression during an excessive inflammatory response.
Golden Meditech Holdings Limited, China's leading integrated healthcare enterprise, is pleased to announce that its medical devices business has successfully raised USD 40 million from a number of renowned private equity investors where the proceeds will fund the construction of new production lines for both medical devices and medical accessories to fund the formation of joint-venture with Fenwal Inc.
Puma Biotechnology, Inc., a development stage biopharmaceutical company, announced that results from ongoing Phase II clinical trials of Puma's investigational drug PB272 (neratinib) were presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium that is currently taking place in San Antonio, Texas.
Veloxis Pharmaceuticals A/S today announced that it has submitted a Marketing Authorization Application to the European Medicines Agency seeking approval to market LCP-Tacro for the prevention of organ rejection in kidney transplant patients in the European Union.
Passport Health, the nation's largest private provider of travel medical services and immunizations, in conjunction with the Mid-Atlantic Chapter of the Africa Travel Association, and Loyola University Maryland's Sellinger School of Business and Management officially announced John McDonough, Secretary of State of MD as the keynote speaker for Rethink Africa.
› Verified 8 days ago